alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 21,051–21,075 of 27,380 studies, newest first · page 843 of 1096.

January 2010 25

  1. 2010-01-01

    A population-based study of cognitive function in older people with subjective memory complaints

    ✓ Peer-reviewed Risk factors Journal of Alzheimer's disease : JAD

    Key finding: SMC were associated with a number of specific objective cognitive deficits including poor verbal fluency, and poor immediate and delayed recall. +2 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2010-01-01

    Visual impairment in Alzheimer's disease: a critical review

    ✓ Peer-reviewed Risk factors Journal of Alzheimer's disease : JAD

    Key finding: Recent studies have demonstrated the potential of visual interventions to improve the functioning of AD patients. +2 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2010-01-01

    Caffeine and adenosine

    ✓ Peer-reviewed Risk factors Journal of Alzheimer's disease : JAD

    Key finding: In conclusion, targeting approaches that involve ARs will enhance the possibilities to correct brain dysfunctions, via the universally consumed substance that is caffeine.

    Full summary, score breakdown and related studies → Original source

  4. 2010-01-01

    Exercise plays a preventive role against Alzheimer's disease

    ✓ Peer-reviewed Prevention trials Journal of Alzheimer's disease : JAD

    Key finding: It is predicted that the incidence of AD will be increased in the future making this disease one of the greatest medical, social, and economic challenges for individuals, families, and the health care system worldwide. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2010-01-01

    Regulation of mitochondrial biogenesis

    ✓ Peer-reviewed Prevention trials Essays in biochemistry

    Key finding: Mitochondrial dysfunction is an important component of different diseases associated with aging, such as Type 2 diabetes and Alzheimer's disease.

    Full summary, score breakdown and related studies → Original source

  6. 2010-01-01

    PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses

    ✓ Peer-reviewed Clinical trials Journal of Alzheimer's disease : JAD

    Key finding: A recent Phase IIa double-blind, randomized, placebo-controlled trial found that the 250 mg dose of PBT2 was well-tolerated, significantly lowered cerebrospinal fluid (CSF) levels of amyloid-beta42, and significantly improved executive function on a Neuro-psychological Test Battery (NTB) within 12 weeks of treatment in patients with AD. +3 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2010-01-01

    The role of GLP-1 in neuronal activity and neurodegeneration

    ✓ Peer-reviewed Drug development Vitamins and hormones

    Key finding: Furthermore, recent research has shown that some GLP-1 analogues can cross the blood-brain barrier, including two that are on the market as a treatment for type 2 diabetes.

    Full summary, score breakdown and related studies → Original source

  8. 2010-01-01

    GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease

    ✓ Peer-reviewed Drug development Journal of Alzheimer's disease : JAD

    Key finding: Type 2 (T2) diabetes mellitus (DM) has been associated with an increased incidence of neurodegenerative disorders, including Alzheimer's disease (AD). +3 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2010-01-01

    Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease

    ✓ Peer-reviewed Drug development Journal of Alzheimer's disease : JAD

    Key finding: We have previously reported anti-amyloidogenic effects of leptin using in vitro and in vivo models and, more recently, demonstrated the ability of leptin to reduce tau phosphorylation in neuronal cells. +4 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2010-01-01

    Clinical uses of melatonin: evaluation of human trials

    ✓ Peer-reviewed Brain scans and imaging Current medicinal chemistry

    Key finding: The conclusion of the current review is that the use of melatonin as an adjuvant therapy seems to be well funded for macular degeneration, glaucoma, protection of the gastric mucosa, irritable bowel syndrome, arterial hypertension, diabetes, side effects of chemotherapy and radiation in cancer patients or hemodialysis in patients with renal insufficiency and, especially, for sleep disorders of circadian etiology (jet lag, delayed sleep phase syndrome, sleep deterioration associated with aging, etc.) as well as in those related with neurological degenerative diseases (Alzheimer, etc.,) or Smith-Magenis syndrome.

    Full summary, score breakdown and related studies → Original source

  11. 2010-01-01

    Structural brain changes in aging: courses, causes and cognitive consequences

    ✓ Peer-reviewed Brain scans and imaging Reviews in the neurosciences

    Key finding: The structure of the brain is constantly changing from birth throughout the lifetime, meaning that normal aging, free from dementia, is associated with structural brain changes.

    Full summary, score breakdown and related studies → Original source

  12. 2010-01-01

    Computerized cognitive assessment in primary care to identify patients with suspected cognitive impairment

    ✓ Peer-reviewed Cognitive tests and assessment Journal of Alzheimer's disease : JAD

    Key finding: Tests currently used in primary care, such as the Mini-Mental State Examination, do not accurately assess patients with mild cognitive impairments, and other tests more suitable for this purpose require further validation and may be too time-consuming in the primary care setting. +4 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2010-01-01

    Amyloid-beta peptide and oligomers in the brain and cerebrospinal fluid of aged canines

    ✓ Peer-reviewed Biomarkers Journal of Alzheimer's disease : JAD

    Key finding: These findings indicate that the Abeta in the brain of the aged canine exhibits patterns that mirror Abeta deposited in the human brain.

    Full summary, score breakdown and related studies → Original source

  14. 2010-01-01

    Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years

    ✓ Peer-reviewed Biomarkers Journal of Alzheimer's disease : JAD

    Key finding: MCI patients with both low Aβ42 and high tau levels had a substantially increased risk of developing AD (OR 20; 95% CI 6-58), even after adjustment for confounding factors.

    Full summary, score breakdown and related studies → Original source

  15. 2010-01-01

    The amnestic syndrome of hippocampal type in Alzheimer's disease: an MRI study

    ✓ Peer-reviewed Hippocampus size on brain scans Journal of Alzheimer's disease : JAD

    Key finding: With VBM analysis, the total score on the FCSRT was correlated with left medial temporal lobe atrophy including the left hippocampus but also the thalami. +4 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2010-01-01

    Hippocampal pathology in schizophrenia

    ✓ Peer-reviewed Hippocampus size on brain scans Current topics in behavioral neurosciences

    Key finding: The underlying cellular substrate is a subtle, yet functionally significant reduction of hippocampal interneurons. +2 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2010-01-01

    Raising the standard: palliative care in nursing homes

    ✓ Peer-reviewed End-of-life care Health affairs (Project Hope)

    Key finding: More than two-thirds of long-stay nursing home residents suffer from dementia. +4 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2010-01-01

    The influence of nursing home culture on the use of feeding tubes

    ✓ Peer-reviewed End-of-life care Archives of internal medicine

    Key finding: The NH culture influences the approach to feeding in advanced cognitive impairment, whether by hand or placement of a feeding tube. +1 more finding

    Full summary, score breakdown and related studies → Original source

  19. 2010-01-01

    Sedation depth during spinal anesthesia and the development of postoperative delirium in elderly patients undergoing hip fracture repair

    ✓ Peer-reviewed Clinical safety Mayo Clinic proceedings

    Key finding: The use of light propofol sedation decreased the prevalence of postoperative delirium by 50% compared with deep sedation. +2 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2010-01-01

    Are certain lifestyle habits associated with lower Alzheimer's disease risk?

    ✓ Peer-reviewed Prevention trials Journal of Alzheimer's disease : JAD

    Key finding: Studies have shown controversial results when it comes to the relation between the adherence to a Mediterranean diet and /or physical activity and the incidence of AD.

    Full summary, score breakdown and related studies → Original source

  21. 2010-01-01

    Cognitive intervention programmes on patients affected by Mild Cognitive Impairment: a promising intervention tool for MCI?

    ✓ Peer-reviewed Prevention trials The journal of nutrition, health & aging

    Key finding: Though both traditional and computer-based cognitive intervention programmes seem to be effective, the computer-based ones present more advantages: 1) they could individualize the programme tailored to the patient's neuropsychological pattern and needs. 2) they permit the user to make an immediate objective comparison with data collected earlier and thus help in setting up a systematic training plan by providing instant value-free feedback. 3) they offer a possibility of a widescale dissemination. +1 more finding

    Full summary, score breakdown and related studies → Original source

  22. 2010-01-01

    Targets for the prevention of dementia

    ✓ Peer-reviewed Prevention trials Journal of Alzheimer's disease : JAD

    Key finding: One study suggested that the cognitive, physical, and social components of activity were of equal importance to cognitive outcomes. +3 more findings

    Full summary, score breakdown and related studies → Original source

  23. 2010-01-01

    Transporters in the brain endothelial barrier

    ✓ Peer-reviewed Disease mechanisms Current medicinal chemistry

    Key finding: It is also known that the Abeta:deposition is inversely correlated with P-gp expression in the brains of elderly non-demented humans. +4 more findings

    Full summary, score breakdown and related studies → Original source

  24. 2010-01-01

    Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging

    ✓ Peer-reviewed Disease mechanisms Journal of neuropathology and experimental neurology

    Key finding: Amyloid-beta accumulation was associated with expression of the Abeta influx transporter, the receptor for advanced glycation end-products (RAGEs) at the blood-brain barrier.

    Full summary, score breakdown and related studies → Original source

  25. 2010 no date recorded — placed by publication year

    Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

    ✓ Peer-reviewed Genetics Alzheimer s Research & Therapy

    Autosomal-dominant Alzheimer's disease has provided significant understanding of the pathophysiology of Alzheimer's disease.

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →